pravastatin has been researched along with Proteinuria in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| de Fijter, JW; Dekker, FW; Dekkers, OM; Esmeijer, K; Hoogeveen, EK | 1 |
| Fujii, T; Iriyama, T; Kumasawa, K; Nagamatsu, T; Osuga, Y | 1 |
| Coombes, JS; Fairley, KF; Fassett, RG; Kincaid-Smith, P; Packham, D | 1 |
| Funauchi, M; Hino, S; Ikoma, S; Kinoshita, K; Kishimoto, K; Nagare, Y; Nozaki, Y; Shimazu, H; Sugiyama, M; Yano, T | 1 |
| D'Haese, P; Geryl, H; Verhulst, A | 1 |
| Cole, T; Curhan, GC; Moyé, L; Sacks, FM; Tonelli, M | 1 |
| Quiroz, Y; Rodríguez-Iturbe, B; Sato, T; Vaziri, ND | 1 |
| Bouchier-Hayes, D; Casey, RG; Chen, G; Joyce, M; Roche-Nagle, G | 1 |
| Chang, NC; Lee, TM; Lin, MS; Tsai, CH | 1 |
| Deray, G; Isnard-Bagnis, C; Karie, S; Launay-Vacher, V | 1 |
| Aranda Arcas, JL; Araque, A; Damiano, A; Guijarro, C; Praga, M; Pulido, F; Sánchez, R | 1 |
| Balletta, M; Bellinghieri, G; Bovino, M; Cianciaruso, B; Colucci, G; Conte, G; Dal Canton, A; Esposito, C; Fuiano, G; Rosa, M; Sepe, V | 1 |
| Alonso-Galicia, M; Roman, RJ; Wilson, TW | 1 |
| Bouchier-Hayes, D; Chen, G; Joyce, M; Kelly, C; Leahy, A; Winter, D | 1 |
| Lee, TM; Su, SF; Tsai, CH | 1 |
2 review(s) available for pravastatin and Proteinuria
| Article | Year |
|---|---|
Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.
Topics: Atorvastatin; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Lovastatin; Network Meta-Analysis; Pravastatin; Proteinuria; Rosuvastatin Calcium; Simvastatin; Treatment Outcome | 2019 |
[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Dyslipidemias; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Graft Rejection; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Pravastatin; Primary Prevention; Prospective Studies; Proteinuria; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors | 2006 |
7 trial(s) available for pravastatin and Proteinuria
| Article | Year |
|---|---|
Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease.
Topics: Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Pravastatin; Prospective Studies; Proteinuria | 2010 |
No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.
Topics: Adult; Aged; Albuminuria; Cross-Over Studies; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Proteinuria; Proteome; Proteomics; Pyrimidines; Retinol-Binding Proteins; Rosuvastatin Calcium; Sulfonamides; Two-Dimensional Difference Gel Electrophoresis | 2011 |
Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease.
Topics: Aged; Creatine Kinase; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Myocardial Infarction; Pravastatin; Proteinuria; Severity of Illness Index; Single-Blind Method | 2003 |
Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Drug Interactions; Drug Resistance; Endothelin-1; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Lipids; Losartan; Male; Middle Aged; Pravastatin; Proteinuria; Substance Withdrawal Syndrome | 2005 |
[Effect of pravastatin on hypercholesterolemia associated with proteinuria].
Topics: Female; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Proteinuria | 1994 |
Effects of hypercholesterolemia of renal hemodynamics: study in patients with nephrotic syndrome.
Topics: Adult; Anticholesteremic Agents; Female; Humans; Hypercholesterolemia; Inulin; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; p-Aminohippuric Acid; Pravastatin; Proteinuria; Renal Circulation; Single-Blind Method | 1996 |
Effect of pravastatin on proteinuria in patients with well-controlled hypertension.
Topics: Adult; Double-Blind Method; Endothelin-1; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lipids; Male; Middle Aged; Multivariate Analysis; Pravastatin; Prospective Studies; Proteinuria; Treatment Outcome | 2002 |
6 other study(ies) available for pravastatin and Proteinuria
| Article | Year |
|---|---|
Pravastatin for preeclampsia: From animal to human.
Topics: Animals; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant, Newborn; Mice; Pravastatin; Pre-Eclampsia; Pregnancy; Premature Birth; Proteinuria | 2020 |
Effect of combining ACE inhibitor and statin in lupus-prone mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Antinuclear; Blood Pressure; Cytokines; Drug Therapy, Combination; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazolidines; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C3H; Mice, Inbred MRL lpr; Pravastatin; Proteinuria; Random Allocation; Specific Pathogen-Free Organisms | 2010 |
AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cholesterol, VLDL; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Male; Olmesartan Medoxomil; Pravastatin; Proteinuria; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Triglycerides | 2004 |
Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pravastatin; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renal Insufficiency; Triglycerides; Urine | 2005 |
Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
Topics: Animals; Blood Pressure; Cholesterol; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diet, Sodium-Restricted; Enzyme Induction; Female; Fenofibrate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Kidney; Kidney Glomerulus; Male; Mixed Function Oxygenases; Pravastatin; Proteinuria; Rats; Rats, Inbred Strains; Sodium, Dietary; Triglycerides; Weight Gain | 1998 |
Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion.
Topics: Animals; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Kidney; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pravastatin; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury | 2001 |